HomeCEFALY Technology

CEFALY Technology

Migraine Abortion Phase 3 Trial (TEAM study) with Cefaly® ACUTE Medical Device is Progressing Quickly

6/18/18: "It's fantastic and the recruitment pace is impressive. It is always a big challenge to enroll patients in clinical phase 3 trials in a timely manner and to keep a steady recruitment pace," said Dr. Pierre Rigaux, the chief executive officer of CEFALY Technology. "With the great organization of this trial we expect it to reach its completion in October, as it was ambitiously planned. We are eager to see the data analysis that is expected to demonstrate that Cefaly® ACUTE is the best acute treatment for migraine attacks and must be used as the first-line treatment."